IP Verse

Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase - EP3626258B1

PatentPatent Analysis

EP3626258

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP19192679A
Filing Date
Jun 25, 2011
Status
Granted And Under Opposition
Jul 2, 2021
Grant Date
Aug 4, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2858679B2
EP2970456B1
EP3103469B1

Bibliography

The patent EP3626258B1 was granted to Shire Human Genetic Therapies on Aug 4, 2021 following the initial filing on Jun 25, 2011 under the application number EP19192679A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GREEN CROSSMay 3, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents